Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
multiple myeloma,relapsed/refractory multiple myeloma,lenalidomide,ixazomib,dexamethasone
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要